Moolec Science Q2 2026 Earnings Report

Moolec Science EPS Results

• Actual EPS: $47.49
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Moolec Science Revenue Results

• Actual Revenue: $2.62 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Moolec Science Announcement Details

• Quarter: Q2 2026
• Date: 5/14/2026
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

Moolec Science (NASDAQ:MLEC) S.A. is an agricultural biotechnology company developing foods and ingredients through molecular farming, a technology that uses plants to produce targeted proteins and other biological compounds. The company’s approach is intended to support the development of more sustainable and scalable alternatives for the food and agriculture industries.

Moolec’s research focuses on producing animal proteins in crops, including soybeans and safflower. Its best-known program, “Piggy Sooy,” uses genetically engineered soybeans designed to produce porcine proteins within the seed, with the goal of creating plant-based ingredients that more closely replicate the taste, texture and nutritional characteristics of animal-derived products. The company has also described additional applications for molecular farming across food and ingredient markets.

Moolec was founded by scientists and entrepreneurs with backgrounds in biotechnology, food production and agriculture. Gastón Paladini serves as chief executive officer and is associated with the Paladini food business in Argentina, while the company’s scientific leadership includes co-founder and chief technology officer Martin Salinas. Moolec has conducted research and development activities in the United States and South America and is listed on the Nasdaq under the symbol MLEC.